NEW PATENTS, WEEK 42, YEAR 2017

New PATENTS

week number 42 year 2017
DEUTERATED KETAMINE

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	WO-2017180589	DEUTERATED KETAMINE	AUSPEX	Mood disorder
2	WO-2017179065	APREMILAST	INDIVISUAL	Behcets disease; Psoriasis; Psoriatic arthritis
3	WO-2017178910	CARMUSTINE	INTAS	Brain tumor; Glioma; Hodgkins disease; Multiple myeloma; Non-Hodgkin lymphoma
4	WO-2017177816	AD 35	ZHEJIANG	Alzheimers disease
5	WO-2017180794	TIGEMOMAM	SKYLINE	Bacterial infection; Pneumonia; Urinary tract infection
6	WO-2017178950	LANREOTIDE	EMCURE	Acromegaly
7	WO-2017178909	EFINACONAZOLE	OLON	topical triazole antifungal
8	WO-2017178524	PYRVINIUM	URQUIMA	Parasitic infection; Worm infection
9	WO-2017177781	SACUBITRIL	CRYSTAL	CARDIAC FAILURE

New patents for New week number 41 year 2017

New patents for New week number 41 year 2017

Sr no	Patent number	name	company	INDICATION	REMARKS, WAIT FOR STR TO APPEAR
1	EP-03228619	APIXABAN	ZAKLADY	Deep vein thrombosis; Lung embolism
2	WO-2017176948	AFOXOLANER	MERIAL		Afoxolaner (INN)[2] is an insecticide and acaricide used in dogs. It is indicated for the treatment and prevention of flea infestations, and the treatment and control of tick infestations in dogs and puppies 8 weeks of age and older, weighing 4 pounds (~1.8 kilograms) of body weight or greater. It is given once a month.[3] Unlike most other flea treatments which are applied topically to the animal's coat, afoxolaner is administered orally in meat-flavoured tablets, and poisons fleas once they start feeding. It is used either alone or as a combination treatment with milbemycin oxime.[4][5][6]
3	WO-2017175854	NASTORAZEPIDE	ZERIA	Peptic ulcer
4	WO-2017175233	CARBETOCIN	INDIVISUAL	Prader-Willi syndrome
5	WO-2017175161	LUMACAFTOR	REDDYS	Cystic fibrosis
6	WO-2017175107	OCTREOTIDE	EMCURE	Acromegaly; Diarrhea; Emesis; Gigantism; Pancreas disease
7	WO-2017175091	LORLATINIB	PFIZER	Metastatic non small cell lung cancer; Neuroblastoma
8	WO-2017175087	APREMILAST	INTAS	Ankylosing spondylitis; Behcets disease; Psoriasis; Psoriatic arthritis
9	WO-2017174691	IDALOPIRDINE	LUNDBECK	Alzheimers disease; Cognitive disorder
10	WO-2017174515	OBETICHOLIC ACID	DIPHARMA	Liver cirrhosis; Non-alcoholic steatohepatitis
11	WO-2017174439	BERPROST	CHINOIN	Peripheral vascular disease; Pulmonary artery hypertension
12	WO-2017174044	IBRUTINIB	ZENTIVA	Lymphoma
13	US-09783485	NITISINONE	DIPHARMA	Type I tyrosinemia
14